Cargando…

Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies

Transmission of the New World hemorrhagic fever arenaviruses Junín virus (JUNV) and Machupo virus (MACV) to humans is facilitated, in part, by the interaction between the arenavirus GP1 glycoprotein and the human transferrin receptor 1 (hTfR1). We utilize a mouse model of live-attenuated immunizatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Weng M., Sahin, Mehmet, Krumm, Stefanie A., Seow, Jeffrey, Zeltina, Antra, Harlos, Karl, Paesen, Guido C., Pinschewer, Daniel D., Doores, Katie J., Bowden, Thomas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040744/ https://www.ncbi.nlm.nih.gov/pubmed/35315691 http://dx.doi.org/10.1128/mbio.02650-21

Ejemplares similares

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection
por: Sommerstein, Rami, et al.
Publicado: (2015)

The Janus Kinase Inhibitor Ruxolitinib Prevents Terminal Shock in a Mouse Model of Arenavirus Hemorrhagic Fever
por: Sahin, Mehmet, et al.
Publicado: (2021)

Structural Basis for a Neutralizing Antibody Response Elicited by a Recombinant Hantaan Virus Gn Immunogen
por: Rissanen, Ilona, et al.
Publicado: (2021)

Emerging Paramyxoviruses: Receptor Tropism and Zoonotic Potential
por: Zeltina, Antra, et al.
Publicado: (2016)

Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses
por: Clark, Lars E., et al.
Publicado: (2018)

Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein
por: Rissanen, Ilona, et al.
Publicado: (2020)

Envelope Exchange for the Generation of Live-Attenuated Arenavirus Vaccines
por: Bergthaler, Andreas, et al.
Publicado: (2006)

A Molecular-Level Account of the Antigenic Hantaviral Surface
por: Li, Sai, et al.
Publicado: (2016)

A Molecular-Level Account of the Antigenic Hantaviral Surface
por: Li, Sai, et al.
Publicado: (2016)

Structural Transitions of the Conserved and Metastable Hantaviral Glycoprotein Envelope
por: Rissanen, Ilona, et al.
Publicado: (2017)

Toremifene interacts with and destabilizes the Ebola virus glycoprotein
por: Zhao, Yuguang, et al.
Publicado: (2016)

Arenaviruses.
por: Casals, J.
Publicado: (1975)

Arenaviruses
por: Gonzalez, J. P., et al.
Publicado: (2007)

A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus
por: Allen, Elizabeth R., et al.
Publicado: (2018)

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
por: Seow, Jeffrey, et al.
Publicado: (2022)

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies
por: Krumm, Stefanie A., et al.
Publicado: (2016)

Arenavirus Budding
por: Urata, Shuzo, et al.
Publicado: (2011)

Structure-Based Classification Defines the Discrete Conformational Classes Adopted by the Arenaviral GP1
por: Pryce, Rhys, et al.
Publicado: (2018)

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
por: Seow, Jeffrey, et al.
Publicado: (2023)

VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display
por: Kingston, Natalie J., et al.
Publicado: (2023)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Novel Arenavirus, Zambia
por: Ishii, Akihiro, et al.
Publicado: (2011)

Envelope Glycoprotein of Arenaviruses
por: Burri, Dominique J., et al.
Publicado: (2012)

Cleavage of the Glycoprotein of Arenaviruses
por: Pasquato, Antonella, et al.
Publicado: (2018)

The HIV glycan shield as a target for broadly neutralizing antibodies
por: Doores, Katie J.
Publicado: (2015)

Arenavirus reverse genetics: New approaches for the investigation of arenavirus biology and development of antiviral strategies
por: Emonet, Sebastien E., et al.
Publicado: (2011)

Immune evasion mechanisms of arenaviruses
por: Ly, Hinh, et al.
Publicado: (2015)

Human Pathogenic Arenaviruses (Arenaviridae)
por: Radoshitzky, Sheli R., et al.
Publicado: (2019)

Arenavirus Quasispecies and Their Biological Implications
por: Grande-Pérez, Ana, et al.
Publicado: (2015)

Validation of Inactivation Methods for Arenaviruses
por: Olschewski, Silke, et al.
Publicado: (2021)

Special Issue “Arenaviruses 2020”
por: Lukashevich, Igor S., et al.
Publicado: (2021)

Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
por: Graham, Carl, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019)

Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies
por: Plagemann, P. G. W., et al.
Publicado: (1992)

Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform
por: Lauterbach, Henning, et al.
Publicado: (2021)

Protein sequence database for pathogenic arenaviruses
por: Bui, Huynh-Hoa, et al.
Publicado: (2007)

Sympatric Occurrence of 3 Arenaviruses, Tanzania
por: Goüy de Bellocq, Joëlle, et al.
Publicado: (2010)

Antibody to Arenaviruses in Rodents, Caribbean Colombia
por: Mattar, Salim, et al.
Publicado: (2011)

Molecular Mechanism of Arenavirus Assembly and Budding
por: Urata, Shuzo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tqupsgf8svra1dhgo3umos9j67